.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
India is currently at a critical inflection point in its medical journey. Dr. Naresh Trehan recently emphasized that preventive healthcare in India must become the primary focus. Consequently, this shift aims to solve the healthcare challenges of 1.5 billion people. Historically, global systems have relied on reactive treatments. However, Trehan argues that proactive prevention is the actual solution for the future.
The global wellness market reached a value of USD 1.8 trillion in 2024. Meanwhile, India's preventive market could reach USD 500 billion by 2030. This growth reflects a significant opportunity for medical innovation and talent. Furthermore, the demographic dividend provides a unique platform for large-scale adult vaccination programs. Rajesh Jain of Panacea Biotech envisions India becoming the preventive capital of the world. Consequently, the production of innovative and scalable vaccines will drive this transformation.
V K Paul from NITI Aayog highlighted the importance of universal health coverage. Currently, out-of-pocket expenses are decreasing as insurance coverage expands. However, the private sector must cover many more individuals to ensure success. India needs a reliable and trustworthy insurance system that remains affordable for the masses. This evolution will empower consumers and improve overall health excellence across the nation.
Q1: Why is a shift to preventive healthcare necessary for India?
Dr. Naresh Trehan argues that a reactive treatment model cannot sustainably manage the health needs of 1.5 billion people. Proactive prevention leverages India's scale and talent to improve health outcomes efficiently.
Q2: What is the projected market value of India's preventive healthcare sector?
India's preventive healthcare market is projected to reach USD 500 billion by the year 2030, driven by consumer empowerment and technological innovation.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Dr. Naresh Trehan emphasizes shifting India's healthcare from reactive treatment to proactive prevention to serve its 1.5 billion people efficiently by 2030...
5 months ago
Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today
Odisha has established India's first state-level clinical protocol specifically tailored for pregnant women with sickle cell disease. Developed with NHM and UNICEF, the framework provides structured antenatal screening, crisis mitigation, standardized referral pathways, and specialized interdisciplinary care.
Today
India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today
A randomized controlled trial demonstrates that an eight-week dual-task training intervention significantly improves static and dynamic postural control over standard balance exercises in individuals with chronic ankle instability, addressing critical neurocognitive deficits during athletic and daily activities.
Today
A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today
